VOGLIGOLD M 0.2

VOGLIGOLD M 0.2 is a fixed-dose combination of voglibose (an alpha-glucosidase inhibitor) and metformin hydrochloride (a biguanide anti-diabetic medicine). This combination is designed to control Type 2 Diabetes Mellitus by addressing both fasting and postprandial blood sugar levels.

• Voglibose delays carbohydrate absorption in the intestine, reducing post-meal sugar spikes.

• Metformin Hydrochloride decreases glucose production in the liver and improves insulin sensitivity.

Together, they provide comprehensive blood sugar control when combined with a balanced diet and regular exercise.

Uses of Voglibose and Metformin Hydrochloride Tablets

The main voglibose and metformin hydrochloride tablets uses include:

• Management of Type 2 Diabetes Mellitus.

• Control of both fasting blood sugar (FBS) and postprandial blood sugar (PPBS).

• Prevention of long-term diabetes complications like kidney damage, nerve damage, heart problems, and vision issues.

• Often prescribed when single-drug therapy is insufficient.

Side Effects of VOGLIGOLD M 0.2

Like any medicine, voglibose and metformin hydrochloride tablets may cause side effects in some patients:

Common Side Effects:

• Flatulence (gas)

• Abdominal discomfort or bloating

• Diarrhea

• Nausea

• Metallic taste in mouth

• Loss of appetite

• Headache

• Mild skin rash or itching

Less Common Side Effects:

• Fatigue or weakness

• Indigestion

• Constipation

• Increased bowel sounds (borborygmi)

• Dizziness

Rare but Serious Side Effects:

• Lactic acidosis (a rare but serious complication from metformin – symptoms include muscle pain, breathing difficulty, severe tiredness)

• Hypoglycemia (especially if combined with other anti-diabetic drugs like sulfonylureas or insulin)

Precautions Before Using VOGLIGOLD M 0.2

Before starting voglibose 0.2 metformin 500, inform your doctor if you:

• Have kidney or liver problems.

• Suffer from heart failure or respiratory issues.

• Have a history of intestinal obstruction or digestive disorders.

• Are pregnant, planning to conceive, or breastfeeding.

• Consume alcohol frequently (increases risk of lactic acidosis).

• Have had allergic reactions to voglibose, metformin, or similar drugs.

Drug Interactions – What Drugs Interact with VOGLIGOLD M 0.2?

Certain medicines may interact with voglibose and metformin hydrochloride tablets:

• Sulfonylureas (e.g., glimepiride, glibenclamide) – may cause low blood sugar.

• Insulin – increases risk of hypoglycemia.

• Diuretics – may increase the risk of lactic acidosis with metformin.

• Corticosteroids – may raise blood sugar levels.

• Beta-blockers – may mask symptoms of hypoglycemia.

• Iodinated contrast agents – may increase the risk of kidney problems and lactic acidosis.

• Digestive enzymes (e.g., amylase, pancreatin) – may reduce voglibose’s effect.